TCG Lifesciences Pvt Ltd.

DUBLIN--( BUSINESS WIRE )--The "World Market for Laboratory Information Systems (LIS): Software, Hardware, and Implementation for Clinical Labs, 2022-2027" report has been added to ResearchAndMarkets.com's offering. This new report examines the current and potential world opportunity for healthcare laboratory information system (LIS) software, hardware, and implementation. The focus of this report is on the market for LIS in clinical diagnostic and healthcare-related labs, although LIMS in pharmaceutical drug discovery laboratories, and other drug research and development labs, are discussed as well. Coverage includes: key trends and other facts about LIS and end-user usage in diagnostic and other clinical laboratories; global and regional revenues for clinical LIS, 2022-2027; CLIA registered laboratories by type of facility, 2015 & 2023; growth in US clinical laboratories, 1997-2023; growth in US hospital laboratory locations, 2011-2023; growth in US independent laboratory facilities, 2011-2023; key LIS selection issues; profiles of selected LIS/LIMS vendors; recent key collaborations and other deals; and key vendor mergers and acquisitions, 2011-2023 This market review examines LIS revenue growth in the clinical LIS area, including: global revenues and marketplace revenues by region, 2022-2027 (United States/North America, Europe, APAC, ROW). The report also reviews the nature and direction of trends and research, and gives insight into some issues facing the industry. Further, large manufacturers that have made names for themselves in the field, as well as smaller firms with market niches are highlighted. These include: Accelerated Technology Laboratories Apex Healthware Aspyra Clinical Software Systems Cerner (Oracle) Clinical Systems Clinisys CLTech International CompuGroup Medical Data Unlimited International Epic Systems LabVantage Solutions LabWare LIMSABC McKesson Ocimum Biosolutions Orchard Software PerkinElmer Psyche Systems Sapio Sciences SCC Soft Computer StarLIMS Technidata Thermo Fisher Scientific XiFin Key Topics Covered: CHAPTER 1: EXECUTIVE SUMMARY WORLD MARKET SUMMARY MARKET OVERVIEW AND POTENTIAL CHAPTER 2: INTRODUCTION OVERVIEW Laboratory Informatics in Flux Connecting the Laboratory and the Patient Variations of LIS/ LIMS Variations For the Drug Industry Variations of LIS For Clinical Laboratories Range of Possible Functions Key Functionality Functionality - Crossover of Features Functionality - Clinical Laboratories Functionality - Verifying Workflow Automation and Competitiveness Opportunities to Expand Integration and Interconnectivity Clinical Diagnostic Integration Electronic Medical Records Point of Care Testing Implications for LIS The Integration Challenge Enterprise Capability Automating Software Benefits and Tradeoffs of LIS Improving Data Management Improved Trackability The Impact of Personalized Medicine CHAPTER 3: TRENDS AND ISSUES TRENDS EMERGING TRENDS - INFORMATICS NO LONGER A SIDE ISSUE Spanning the Interface Data Mobility Robust and Adaptable Commercial Off-the-Shelf Systems COTS - Virtues and Drawbacks COTS - Some Customization Needed Software-as-a-Service (SaaS) SaaS - Changing the Face of the Industry Open Architecture Open Source - Customization For the Clinical Lab Reducing Costs Cost Reduction - Standardization Cost Reduction - Rental Option Significant Laboratory Challenges Challenging Choice of Systems Challenge of Evolving Technology Key Questions from Users Vendor Challenges and Concerns The Interface Challenge Configurability Desired CHAPTER 4: MARKET POTENTIAL MARKET REVENUE AND FORECAST Perspective Managing the Data Tsunami Harnessing Sequencing Data REPLACEMENT MARKET OPPORTUNITIES Adaptability Is Key LABORATORY MARKET SYNOPSIS Structure Types of Testing Laboratory Types and Growth Demographics Push Demand Reimbursement Trends International Laboratory Growth Trends MARKETPLACE IMPETUS GROWTH DRIVERS THE CLINICAL LABORATORY MARKET MARKET FORECAST THE GROWING NGS MARKET FOR LIMS CHAPTER 5: MARKET PARTICIPANTS Accelerated Technology Laboratories Apex Healthware Aspyra Clinical Software Systems Cerner (Oracle) Clinical Systems Clinisys CLTech International CompuGroup Medical Data Unlimited International Epic Systems LabVantage Solutions LabWare LIMSABC McKesson Ocimum Biosolutions Orchard Software PerkinElmer Psyche Systems Sapio Sciences SCC Soft Computer StarLIMS Technidata Thermo Fisher Scientific XiFin For more information about this report visit https://www.researchandmarkets.com/r/2arih4 About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

DUBLIN, Sept. 11, 2023 /PRNewswire/ -- The "Global Laboratory Information System (LIS) Market by Product (Standalone, Integrated), Component (Services, Software), Delivery Mode (On-premise, Cloud-based), End-user (Hospital Laboratories, Independent Laboratories, POLs) and Region - Forecast to 2028" report has been added to ResearchAndMarkets.com's offering. The global laboratory information systems market is anticipated to grow from an estimated USD 2.4 billion in 2023 to USD 4 billion in 2028, at a CAGR of 10.8% The market has a promising growth potential due to the development of integrated LIS. Integrated LIS solutions help ease lab workflow, provide standardized and quality diagnosis, enable simplified solution deployment, and help in reducing the cost associated with installing new and independent LIS systems. In addition, offering lower maintenance costs to the end-users would help improve the market growth. However, data storage challenges are expected to limit the growth of this market to a certain extent. Independent Laboratories: The fastest-growing segment of the laboratory information systems market, by end-user Based on the end-user, the LIS market is broadly segmented into hospital laboratories, independent laboratories, physician office laboratories (POLs), and other end-users (blood banks, retail clinics, public health labs, and nursing homes). The independent laboratories segment is expected to witness the fastest growth in the laboratory information systems market during the forecast. This is owing to the rising demand for LIS among independent laboratories for managing workflows, enhancing billing processes, and improving turnout times. Favorable reimbursement policies for laboratory diagnosis under the Protecting Access to Medicare Act of 2014 (PAMA) and the Bundled Payments initiative are also driving the adoption of LIS in independent laboratories. The services segment is anticipated to be the largest laboratory information systems market, by component, during the forecast period Based on components, the market is segmented into services and software. The services segment accounted for the largest share of the laboratory information systems market. LIS services include consulting, implementation and ongoing IT support, training and education, and maintenance services. The large share of the services segment can be majorly attributed to their indispensable nature and repetitive requirement, as well as the heavy dependency of end-users on service providers for consulting, storage, implementation of solutions, training, maintenance, and regular upgrades. Europe accounted for the second-largest share in the laboratory information systems market during the forecast period Europe accounted for the second-largest share of the laboratory information systems market during the forecast period. The major factors driving the LIS market in Europe include the rising prevalence of chronic diseases, the growing geriatric population, and government initiatives to promote HCIT. Germany, the UK, and France are the major contributors to the growth of the LIS market in Europe. Currently, Europe is witnessing a shortage of lab professionals across all industries (due to the challenging economic environment) and increased migration of lab personnel to other sectors or countries. This factor is compelling laboratories in the region to move towards automation. This has resulted in the growing adoption of LIS solutions, as they act as an integral component in automating laboratory workflow processes. On the other hand, factors such as growing concerns over data security and uncertain economic conditions are expected to hamper the growth of the LIS market in Europe. Key Attributes: Premium Insights Development of Integrated LIS to Drive Market Growth North America to Dominate Laboratory Information Systems Market During Forecast Period India to Register Highest Revenue Growth from 2023 to 2028 Hospital Laboratories and US Dominated Market in North America in 2022 Standalone LIS Segment Held Larger Market Share in 2022 Services Segment to Dominate Market in 2028 Cloud-based LIS to Register Higher Growth Rate During Forecast Period Hospital Laboratories to Account for Largest Market Share in 2028 Market Dynamics Drivers Need for Laboratory Automation Development of Integrated LIS Rising Prevalence of Chronic Diseases Growing Demand for LIS in Biobanks/Biorepositories Need to Comply with Regulatory Requirements Increasing Adoption of LIS to Enhance Lab Efficiency Restraints High Maintenance and Service Costs Lack of Integration Standards for LIS Opportunities Growing Popularity of Cloud-based LIS Growth Potential of Emerging Countries Rising Demand for Personalized Medicine Challenges Interfacing with Diverse Laboratory Instruments Requirement of Specialized LIS Solutions Data Storage Challenges Dearth of Trained Laboratory Professionals Industry Insights Overview of Key Industry Trends Shift to Value-based and Patient-Centric Care Mobile Applications and Point-of-Care Testing Advanced Analytics and Artificial Intelligence (AI) Technology Analysis Machine Learning Artificial Intelligence Internet of Things Blockchain Cloud Computing Company Profiles Key Players Orchard Software Corporation Clinisys Oracle Corporation Computer Programs and Systems, Inc. CompuGroup Medical Soft Computer Consultants, Inc. (SCC Soft Computer) American Soft Solutions Corp. Epic Systems Corporation Altera Digital Health Aspyra Comp Pro Med Inc. Computer Service & Support, Inc. Clinical Software Solutions GPI S.p.A. Ligolab Information System LabWare LabVantage Solutions, Inc. Xifin, Inc. Seacoast Laboratory Data Systems Veradigm LLC Other Players WebPathLab Apex Healthware Technidata Pathagility Hex Laboratory Systems CliniSis Alphasoft Dendi, Inc. For more information about this report visit About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Media Contact: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Logo: SOURCE Research and Markets

HEILBRONN, Germany, Jan. 31, 2023 /PRNewswire/ -- ProtaGene, GmbH, a leading global contract research organization focused on advanced analytics in biologics and cell and gene therapy, announced today the appointment of Jennifer Chadwick, Ph.D., as Chief Scientific Officer and Owen Hitchins as Chief Commercial Officer. Working in close collaboration, accomplished executive leaders Chadwick and Hitchins will utilize their respective experience to meet the rapidly evolving needs of the advanced biotherapeutics development community. "Innovators in today's biopharmaceutical industry are working to bring increasingly complex products to market, which means greater challenges and unknowns along the development path where quality and regulatory expectations continue to evolve," said Chadwick. "As a strategic partner to numerous innovators, we provide solutions for the development of emerging therapeutics, so our team has a unique advantage in understanding the development landscape into which analytics fit. Our elevated approach to working with partners enables us to provide analytical solutions for diverse gene therapies and complex protein-based biotherapeutics. Because these therapeutics do not play by the rules, developers leverage our expertise and excellent results to help make proactive decisions, recalibrate when the unexpected happens, or respond when regulatory expectations adjust based on new understandings." Prior to the formation of ProtaGene, Chadwick played several roles within the BioAnalytix organization, most recently as Vice President of Analytical Development. For over a decade before transitioning to industry, she was a professor of pharmaceutical chemistry at the University of Kansas, where she advised and collaborated extensively with industry partners, and research in her lab led to key discoveries that helped advance the understanding of how molecular attributes influence the stability of complex biologics. Hitchins began his career at Beckman Instruments (now Beckman Coulter) and has held numerous positions within industry-leading organizations such as Thermo Fisher Scientific, Indigo Biosystems, and LabVantage Solutions. Before joining ProtaGene, he was the Global Executive Director of Business Development, CMC for Covance (now Labcorp). "When I learned Protagen Protein Services, BioAnalytix, and GeneWerk were merging to form ProtaGene, I was excited by the great potential of the combined organization, and I knew that I wanted to be part of it," said Hitchins. "The biotherapeutics being developed today are simply amazing, but developers need advanced analytics to accelerate their work and to make developing these therapies possible. To be able to use my career-long experience in the life sciences sector to help advance these therapies, ultimately improving the lives of patients in need, is thrilling." The combination of Chadwick's and Hitchins's expertise promises to accomplish a great deal and fill many of the market's pressing needs. "There will be a very close collaboration between our business development and scientific teams to align the organization's efforts and investments in analytical innovation so that we continue to meet marketplace needs in the right ways," said Chadwick in closing. "The biologics and cell and gene therapy space will continually advance. Our teams are here to help our clients with important decisions as the science, industry, and regulatory expectations evolve." About ProtaGene ProtaGene is a world-leading Contract Research Organization partner for the biopharmaceutical and cell and gene therapy industries. ProtaGene provides the most advanced, integrated, and complete protein and gene analytic capabilities and packages from discovery to product commercialization. A unique combination of protein- and gene-based analytical platforms makes ProtaGene the leading analytic service provider in biologics and cell and gene therapy development. The organization operates four sites in Europe and North America and works in advanced therapeutic platforms with leading biopharmaceutical and gene therapy companies worldwide. Additional information is available at . SOURCE ProtaGene